Carcinoma, Papillary
Showing 51 - 75 of 8,345
Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States
Recruiting
- Adenoid Cystic Skin Carcinoma
- +38 more
- Biopsy
- +6 more
-
Los Angeles, California
- +35 more
Jan 31, 2023
Papillary Thyroid Microcarcinoma Trial in Tianjin, Hangzhou, Kharkiv (Radiofrequency Ablation, Conventional Surgery)
Recruiting
- Papillary Thyroid Microcarcinoma
- Radiofrequency Ablation
- Conventional Surgery
-
Tianjin, Tianjin, China
- +2 more
Dec 16, 2020
Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Type 1, Papillary Renal Cell Carcinoma Type 2 Trial in Australia
Active, not recruiting
- Renal Cell Carcinoma
- +5 more
-
Albury, New South Wales, Australia
- +18 more
Feb 14, 2022
Hereditary Pancreatic Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Tumor Trial in Portland
Recruiting
- Hereditary Pancreatic Carcinoma
- +2 more
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- Ferumoxytol
-
Portland, OregonOHSU Knight Cancer Institute
Aug 16, 2022
Acinar Cell Carcinoma, Ampulla of Vater Adenocarcinoma, Cholangiocarcinoma Trial in Cleveland, Philadelphia (Pancreatectomy,
Recruiting
- Acinar Cell Carcinoma
- +7 more
- Pancreatectomy
- Lavage
-
Cleveland, Ohio
- +1 more
Sep 7, 2022
Thyroid Cancer, Thyroid Cancer, Medullary, Differentiated Thyroid Cancer Trial in Tampa (Lenvatinib, Sorafenib, Cabozantinib)
Terminated
- Thyroid Cancer
- +5 more
- Lenvatinib
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jul 12, 2021
Inflammatory Breast Cancer, Invasive Ductal Breast Carcinoma, Invasive Lobular Breast Carcinoma Trial in New Brunswick, Salt
Active, not recruiting
- Inflammatory Breast Cancer
- +9 more
- External beam radiation therapy
-
New Brunswick, New Jersey
- +1 more
Jan 30, 2022
Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma, Unclassified Renal Cell Carcinoma, Papillary Renal Cell Carcinoma
Recruiting
- Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma
- +6 more
-
Basking Ridge, New Jersey
- +6 more
Feb 2, 2022
Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States
Active, not recruiting
- Ovarian Brenner Tumor
- +11 more
- Adavosertib
- +5 more
-
Duarte, California
- +15 more
Aug 11, 2022
Microbiome and Papillary Thyroid Microcarcinoma
Not yet recruiting
- Papillary Thyroid Microcarcinoma
- Microbiome
- Thyroidectomy
- (no location specified)
Jun 28, 2020
Treating Patients With Stage IV Breast Cancer
Active, not recruiting
- Central Nervous System Metastases
- +15 more
- hyperfractionated radiation therapy
- +2 more
-
North Chicago, IllinoisUniversity of Chicago
Dec 6, 2021
RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide
Active, not recruiting
- RET-altered Non Small Cell Lung Cancer
- +39 more
- pralsetinib (BLU-667)
-
Phoenix, Arizona
- +65 more
Nov 10, 2022
Carcinoma, Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Savolitinib, Sunitinib)
Active, not recruiting
- Carcinoma
- +7 more
-
La Jolla, California
- +58 more
Jan 13, 2023
Low Risk Papillary Thyroid Cancer
Recruiting
- Papillary Thyroid Cancer
- +2 more
-
Halifax, Nova Scotia, Canada
- +4 more
Feb 3, 2021
Renal Cell Carcinoma, Hereditary Leiomyomatosis, Renal Cell Cancer Trial run by the NCI (Vandetanib, Metformin,
Terminated
- Renal Cell Carcinoma
- +2 more
- Vandetanib
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 12, 2021
Thyroid Carcinoma, Thyroid Cancer, Thyroid Cancer, Follicular Trial in United States (I-124 PET/CT lesion dosimetry,
Recruiting
- Thyroid Carcinoma
- +5 more
- I-124 PET/CT lesion dosimetry
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Mar 3, 2022
Uterine Cancer Trial in Houston (Imatinib Mesylate, Paclitaxel)
Terminated
- Uterine Cancer
- Imatinib Mesylate
- Paclitaxel
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 26, 2020
Thyroid Tumors Trial in Worldwide (Vandetanib, Placebo)
Percentage of BRAFV600E Alleles and Outcome in Thyroid Carcinoma
Not yet recruiting
- Papillary Thyroid Cancer
-
Baronissi, Salerno, ItalyDepartment of Medicine and Surgery, Univeristy of Salerno
Dec 10, 2020
Xpert® Bladder Cancer Monitor Test.
Completed
- Non-Invasive Bladder Urothelial Carcinoma
- +2 more
- Xpert® Bladder Cancer Monitor Test
-
Montpellier, Hérault, FranceClinique Beau Soleil
Feb 8, 2021
Central Neck Dissection in Stage N0 Papillary Thyroid Carcinoma
Unknown status
- Papillary Thyroid Cancer
- central neck dissection
-
Asyūţ, Asyut, EgyptAhmed Kamel
Jul 10, 2020
Refractory Differentiated Thyroid Gland Carcinoma, Refractory Thyroid Gland Follicular Carcinoma, Refractory Thyroid Gland
Completed
- Refractory Differentiated Thyroid Gland Carcinoma
- +4 more
- Cediranib
- +3 more
-
Duarte, California
- +32 more
Jun 24, 2021
Non-Invasive Papillary Carcinoma of Bladder Trial in Germany, Italy, Spain (Oncofid-P-B)
Completed
- Non-Invasive Papillary Carcinoma of Bladder
-
Essen, Germany
- +13 more
Dec 8, 2020